Sclerosis News and Research

RSS

Breakthrough research reveals potential path toward a cure for ALS

In a groundbreaking Canadian discovery powered by philanthropy, a team of Western University researchers led by Dr. Michael Strong has uncovered a potential path toward a cure for amyotrophic lateral sclerosis (ALS).

13 May 2024

Underdiagnosed and common: Study highlights neuropathy's hidden toll

Neuropathy, the nerve damage that causes pain and numbness in the feet and hands and can eventually lead to falls, infection and even amputation, is very common and underdiagnosed, according to a study published in the May 8, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

8 May 2024

Brain-computer interface translates ALS patient's brain activity into spoken words

Researchers successfully used a brain-computer interface to synthesize speech directly from brain activity in an ALS patient, achieving 80% word recognition accuracy by listeners, showcasing the interface's potential for aiding communication in severe speech impairments.

8 May 2024

MS Australia urges government action on neurological research funding

MS Australia has welcomed the Government's pledge to invest in health and medical research but is concerned that not enough attention or funding is being dedicated to neurological research.

8 May 2024

Broken String Biosciences and the Francis Crick Institute collaborate to advance ALS research

Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis.

From Broken String Biosciences 7 May 2024

Researchers unveil mechanism enhancing cellular fitness against aging and neurodegeneration

Researchers at Duke University Medical Center discover a mechanism to enhance the fitness of cells against aging and neurodegenerative diseases. This finding will pave the way for novel therapeutic approaches in neuroprotection against aging-related disorders and neurodegeneration.

6 May 2024

Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged

Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs).

3 May 2024

Columbia researchers uncover brain's ability to control inflammation

The brain can direct the immune system to an unexpected degree, capable of detecting, ramping up and tamping down inflammation, shows a new study in mice from researchers at Columbia's Zuckerman Institute.

2 May 2024

Study reveals delayed recognition of nonmotor seizures in children and teens

Children and teens may experience nonmotor seizures for months or years before being seen in an emergency department for a more obvious seizure that includes convulsions, according to a study published in the May 1, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

2 May 2024

Garvan Institute and Illumina collaborate to transform the treatment of complex diseases

Illumina, a global genomics and human health company, has partnered with the Garvan Institute of Medical Research's TenK10K project to help transform the treatment of complex diseases, starting with autoimmune diseases, with a joint investment of $27 million AUD.

30 Apr 2024

PET brain scans could reveal hidden inflammation in patients with multiple sclerosis

A Brigham and Women’s Hospital study of 30 people found that, in patients with MS, advanced brain imaging could identify hidden inflammation not picked up on traditional MRIs

27 Apr 2024

Exploring the potential of ketogenic diets in managing epilepsy

The mechanisms of action, efficacy, and side effects of ketogenic diet (KD) variations in epileptic patients.

26 Apr 2024

Synthetic nanomaterial could be an effective tool for treating neurodegenerative diseases

A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer's and other neurodegenerative diseases.

25 Apr 2024

Study links acid-reducing drugs to increased risk of migraine

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.

24 Apr 2024

Investigating the efficacy and safety of existing drugs in patients with rare immune diseases

This month the first study within the DRIMID consortium (DRIMID stands for Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases) has started.

23 Apr 2024

Breakthrough study reveals role of histone deacetylases in inflammatory bowel disease

In a scientific breakthrough, Mount Sinai researchers have revealed the biological mechanisms by which a family of proteins known as histone deacetylases (HDACs) activate immune system cells linked to inflammatory bowel disease (IBD) and other inflammatory diseases.

22 Apr 2024

Sclerosis News and Research

Breakthrough research reveals potential path toward a cure for ALS

Underdiagnosed and common: Study highlights neuropathy's hidden toll

Brain-computer interface translates ALS patient's brain activity into spoken words

MS Australia urges government action on neurological research funding

Broken String Biosciences and the Francis Crick Institute collaborate to advance ALS research

Researchers unveil mechanism enhancing cellular fitness against aging and neurodegeneration

Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged

Columbia researchers uncover brain's ability to control inflammation

Study reveals delayed recognition of nonmotor seizures in children and teens

Garvan Institute and Illumina collaborate to transform the treatment of complex diseases

PET brain scans could reveal hidden inflammation in patients with multiple sclerosis

Exploring the potential of ketogenic diets in managing epilepsy

Synthetic nanomaterial could be an effective tool for treating neurodegenerative diseases

Study links acid-reducing drugs to increased risk of migraine

Investigating the efficacy and safety of existing drugs in patients with rare immune diseases

Breakthrough study reveals role of histone deacetylases in inflammatory bowel disease

Mitochondrial depletion in axons linked to protein accumulation in neurodegenerative diseases

Study identifies potential strategy to diminish the devastating impacts of traumatic brain injuries

Blood test may predict MS development, UCSF research reveals

Fitness trackers and smartphones offer insights into multiple sclerosis management

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News